SEARCH

SEARCH BY CITATION

References

  • Ali S, Lutz Y, Bellocq JP, Chenard-Neu MP, Rouyer N and Metzger D (1993) Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor. Hybridoma, 12, 391405.
  • Baek SH, Woo SK, Lee JI, Yoo YJ, Cho CM, Kang MS, Tanaka K and Chung CH (1997) New de-ubiquitinating enzyme, ubiquitin C-terminal hydrolase 8, in chick skeletal muscle. Biochem J, 325, 325330.
  • Boddy MN, Howe K, Etkin LD, Solomon E and Freemont PS (1996) PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene, 13, 971982.
  • Brown MT, Goetsch L and Hartwell LH (1993) MIF2 is required for mitotic spindle integrity during anaphase spindle elongation in Saccharomyces cerevisiae. J Cell Biol, 123, 387402.
  • Carvalho T, Seeler JS, Öhman K, Jordan P, Pettersson U, Akusjärvi G, Carmo-Fonseca M and Dejean A (1995) Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol, 131, 4556.
  • Castaigne S, Chomienne C, Daniel M, Ballerini P, Berger R, Fenaux P and Degos L (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. (I) Clinical results. Blood, 76, 17041709.
  • Chang KS, Fan YH, Andreeff M, Liu J and Mu ZM (1995) The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood, 85, 36463653.
  • Chen GQ et al. (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML–RAR alpha/PML proteins. Blood, 88, 10521061.
  • Ciechanover A (1994) The ubiquitin–proteasome proteolytic pathway. Cell, 79, 1321.
  • de Thé H, Lavau C, Marchio A, Chomienne C, Degos L and Dejean A (1991) The PML–RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675684.
  • Deshaies RJ (1997) Phosphorylation and proteolysis: partners in the regulation of cell division in budding yeast. Curr Opin Genet Dev, 7, 716.
  • Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM and Maul GG (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev, 10, 196207.
  • Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A and Evans RM (1994) A novel macromolecular structure is a target of the promyelocyte–retinoic acid receptor oncoprotein. Cell, 76, 333343.
  • Everett RD and Maul GG (1994) HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J, 13, 50625069.
  • Everett R, O'Hare P, O'Rourke D, Barlow P and Orr A (1995) Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures. J Virol, 69, 73397344.
  • Everett RD, Meredith M, Orr A, Cross A, Kathoria M and Parkinson J (1997) A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J, 16, 15191530.
  • Gaub M-P, Rochette-Egly C, Lutz Y, Ali S, Matthes H, Scheuer I and Chambon P (1992) Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res, 201, 335346.
  • Goddard AD, Borrow J, Freemont PS and Solomon E (1991) Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science, 254, 13711374.
  • Guldner HH, Szostecki C, Grötzinger T and Will H (1992) IFN enhances expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol, 149, 40674073.
  • Hochstrasser M (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol, 7, 215223.
  • Hochstrasser M (1996) Protein degradation or regulation: Ub the judge. Cell, 84, 813815.
  • Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhao L, Gu LJ and Wang ZY (1988) Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567571.
  • Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVVS, Dmitrovsky E and Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell, 66, 663674.
  • Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, Lanotte M, Berger R and Chambon P (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J, 11, 629642.
  • Kelly C, van Driel R and Wilkinson GWG (1995) Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J Gen Virol, 76, 28872893.
  • Koken MHM et al. (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J, 13, 10731083.
  • Korioth F, Gieffers C, Maul GG and Frey J (1995) Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol, 130, 113.
  • Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valenzi F and Berger R (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acyte promyelocytic leukemia (M3). Blood, 77, 10801086.
  • Lapenta V, Chiurazzi P, van der Spek P, Pizzuti A, Hanaoka F and Brahe C (1997) SMT3A, a human homologue of the S.cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family. Genomics, 40, 362366.
  • Lavau C et al. (1995) The acute-promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene, 11, 871876.
  • Mahajan R, Delphin C, Guan T, Gerace L and Melchior F (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell, 88, 97107.
  • Mannen H, Tseng HM, Cho CL and Li SS (1996) Cloning and expression of human homolog HSMT3 to yeast SMT3 suppressor of MIF2 mutations in a centromere protein gene. Biochem Biophys Res Commun, 222, 178180.
  • Matunis MJ, Coutavas E and Blobel G (1996) A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol, 135, 14571470.
  • Maul GG, Guldner HH and Spivack JG (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol, 74, 26792690.
  • Meluh PB and Koshland D (1995) Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Mol Biol Cell, 6, 793807.
  • Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM and Yeh ET (1996) Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol, 15, 42774281.
  • Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F and Pelicci PG (1991) Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene, 6, 12851292.
  • Reddy BA, Etkin LD and Freemont PS (1992) A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci, 17, 344345.
  • Saitoh H, Pu R, Cavenagh M and Dasso M (1997) RanBP2 associates with Ubc9p and a modified form of RanGAP1. Proc Natl Acad Sci USA, 94, 37363741.
  • Seufert W, Futcher B and Jentsch S (1995) Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature, 373, 7881.
  • Shen Z, Pardington-Purtymun PE, Comeaux JC, Moyzis RK and Chen DJ (1996) UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics, 36, 271279.
  • Stadler M et al. (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene, 11, 25652573.
  • Sternsdorf T, Guldner H, Szostecki C, Grötzinger T and Will H (1995) Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol, 42, 257268.
  • Szostecki C, Guldner HH, Netter HJ and Will H (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol, 145, 43384347.
  • Treier M, Staszewski LM and Bohmann D (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell, 78, 787798.
  • Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A and Dejean A (1994) Retinoic acid regulates aberrant nuclear localization of PML–RARα in acute promyelocytic leukemia cells. Cell, 76, 345356.
  • Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R and Naoe T (1996) Accelerated degradation of PML–retinoic acid receptor alpha (PML–RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res, 56, 29452948.
  • Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z and de Thé H (1997) Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci USA, 94, 39783983.